par Dequiedt, Franck;Willems, Lucas 
;Kerkhofs, Pierre ;Burny, Arsène ;Kettmann, Richard
Référence Veterinary immunology and immunopathology, 59, 3-4, page (311-322)
Publication Publié, 1997-11
;Kerkhofs, Pierre ;Burny, Arsène ;Kettmann, Richard Référence Veterinary immunology and immunopathology, 59, 3-4, page (311-322)
Publication Publié, 1997-11
Article révisé par les pairs
| Résumé : | As a cyclin-dependent kinases (Cdks) inhibitor (CDI), the protein p21(WAF1/CIP1) is able to interfere with cell cycle progression. Its expression is upregulated by wild-type p53, and the p21(WAF1/CIP1) protein appears to be a potent effector of the p53-dependent cell cycle regulatory pathway. We have previously reported that p53 mutations frequently occur during bovine leukemia virus (BLV)-induced leukemogenesis in cattle but not in sheep. Therefore, we have investigated the involvement of p21(WAF1/CIP1) mutations in the tumorigenic process associated with BLV. We first cloned the bovine and ovine WAF1 genes and determined the complete nucleotide sequences of their second coding exons. These sequences share respectively 79% and 80% homology with those of the human counterpart exon. In order to screen for mutations that could be associated with BLV-induced pathogenicity, we performed single strand conformation polymorphism (SSCP) assays on the WAF1 genes from BLV-induced tumors. No WAF1 mutations were detected in any of the ten BLV-induced bovine tumor samples. Among eleven sheep tumors and three ovine cell lines, only one sample revealed a single mutation in the WAF1 coding sequence, but this mutation was silent at the translational level. We concluded that mutations of the WAF1 gene are not involved in the development of the tumors during BLV-induced leukemogenesis. |
